The effect of garlic on quality of life and improvement of cardiac function in patients with heart failure

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181121041715N1

Enrollment

140

Registered

2020-08-18

Start date

2020-08-20

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure. Heart failure

Interventions

Control group: The patient who receives the placebo.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with heart failure in the age range of 18 years and above. For patients diagnosed at least 3 months in advance according to the New York Heart Association classification in Class III and II Their discharge fraction is reported to be less than 45%. Receiving common and standard medications for heart failure. Women should not be pregnant or breastfeeding and should use safe methods of contraception at reproductive age Do not suffer from mental illnesses, thyroid, anemia, obstructive pulmonary disease, malignancies, hepatitis, kidney and liver failure, uncontrolled diabetes and uncontrolled hypertension, gastrointestinal diseases. The patient's blood pressure is below 100/180.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
EF. Timepoint: EF-40. Method of measurement: ECKO.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsima azish

Esfahan University of Medical Sciences

sima.azish@yahoo.com+98 31 3261 1406

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026